̽»¨¾«Ñ¡

I am Team Leader in Maja Jagodic's group of the Karolinska Neuroimmunology and Multiple Sclerosis (KNIMS) network.

Grants: the Swedish Research Council (VetenskapsrÃ¥det), The Swedish Brain Foundation (Hjärnfonden), the Swedish Association for Persons with Neurological Disabilities (Neuroförbundet), the Swedish MS Foundation (MS Forskningsfonden), The Norlins Foundation, Magnus Bergvalls Foundation, Petrus och Augusta Hedlunds  Foundation, Ã…ke Wiberg Foundation, Margaretha af Ugglas Foundation, ̽»¨¾«Ñ¡ Research Foundation.

Short bio: I have a PhD in Human Physiology and Physiopathology (highest honours), Pierre et Marie Curie University (UPMC – Sorbonne Universités), Sept 2011, Paris,  France. Before that, I obtained a Research Master in Physiology and Physiopathology (/cum laude/), Rennes 1 
University, June 2007, Rennes, France and an Engineering Degree in Life Science, ENSAR, July 2007, France.

I aim to exploit the /potential of epigenetics to better understand and treat neuroinflammatory and neurodegenerative disorders, with a focus on Multiple Sclerosis disease. I have a particular interest in unraveling the molecular mechanisms along the lung-brain axis that underlie the impact of smoking in disease development and severity. By integrating state-of-art methodological and causal approaches in molecular, cellular and experimental neuroscience into a clinical framework, I hope to fully translate novel knowledge into clinical applications, with the prospect to potentially /revolutionize translational research and personalized medicine. My expertise relies on robust theoretical and practical knowledge in in-vivo studies of models of neuropathology as well as diverse molecular and cellular skills in epigenetics and neuroscience that I acquired during my career. In a word, my scientific ambition is driven by a rooted passion for epigenetics and ever-growing motivation to unravel its potential in clinical neuroscience. My research is embedded in a highly collaborative and dynamic research center: Karolinska Neuroimmunology and Multiple Sclerosis (KNIMS) network.